Featured Research

from universities, journals, and other organizations

Heart failure patients who develop kidney failure after LVAD surgery don't fare well, study finds

Date:
April 22, 2010
Source:
Henry Ford Health System
Summary:
Heart failure patients who develop kidney failure after receiving a mechanical heart pumping device are at increased risk of dying within in the first three years of surgery, according to a new study.

Heart failure patients who develop kidney failure after receiving a mechanical heart pumping device are at increased risk of dying within in the first three years of surgery, according to a Henry Ford Hospital study.

Researchers found that 35 percent of patients who developed kidney failure died within 180 days after surgery compared to zero patients who did not develop kidney failure. The mortality rate worsened to 52 percent at three years post-surgery for patients who developed kidney failure versus 35 percent who did not develop kidney failure.

The study also showed the kidney failure patients endured longer stays in the intensive care unit and longer hospitalizations than those who did not develop kidney failure post-surgery.

The study was presented at the International Society of Heart and Lung Transplant in Chicago.

"The short-term and long-term survival of these patients is worrisome," says Jeffrey Morgan, M.D., the study's lead author and associate director of Henry Ford's Circulatory Assist Device Program and Cardiac Transplantation.

"Future study is needed to look at developing a mathematical model that could predict the risk of kidney failure in certain patient populations and lead to improved patient outcomes."

The study followed 41 heart failure patients implanted with a left ventricular assist device, or LVAD, between March 2006 and June 2009 at Henry Ford. An LVAD is a battery-operated pumping device surgical implanted to help the pumping ability of the heart.

Researchers compared the survival rates and hospitalizations of 15 patients who developed kidney failure after surgery to the 26 patients who did not.

Researchers found that survival significantly decreased among the kidney failure patients at 30 days, 180 days, one year and three years compared to patients who did not develop kidney failure after surgery. The kidney failure patients also spent on average 15 days in the intensive compared to seven days for the non kidney failure patients in the first 30 days after surgery.

Dr. Morgan theorizes that improvement in patient selection and limiting a patient's time on the cardio-pulmonary bypass machine can reduce the risk of patients developing kidney failure after surgery.

The study was funded by Henry Ford Hospital.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Heart failure patients who develop kidney failure after LVAD surgery don't fare well, study finds." ScienceDaily. ScienceDaily, 22 April 2010. <www.sciencedaily.com/releases/2010/04/100422153808.htm>.
Henry Ford Health System. (2010, April 22). Heart failure patients who develop kidney failure after LVAD surgery don't fare well, study finds. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/04/100422153808.htm
Henry Ford Health System. "Heart failure patients who develop kidney failure after LVAD surgery don't fare well, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/04/100422153808.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins